Joanna Szymocha

Joanna Szymocha

Auto-generated profile, based on publicly available information

Joanna Szymocha

The District Hospital in Zawiercie, Miodowa 14, 42-400 Zawiercie, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2026 in Quality in Sport
Verified
Journal Article
Open access
APArkadiusz Psiuk
Arkadiusz Psiuk
JSJoanna Szymocha
Joanna Szymocha
ISIgor SmęDowski
Igor SmęDowski
JTJarosław Tsukerman
Jarosław Tsukerman
AWAleksandra Wojas
Aleksandra Wojas
Background: Sport occupies an ambivalent position in mental health scholarship, serving both as a resource for well-being and as a setting in which structural stigma, interpersonal prejudice, and chronic stressors may converge to produce psychological harm. Minority stress theory and emerging work on affective polarization may offer complementary lenses for understanding how social conditions translate into individual outcomes among athletes from sexual, gender, and racial minority backgrounds. Aim: This narrative review aimed to synthesize the available literature on minority stress, social polarization, and mental well-being and functioning within sporting environments, with attention to conceptual foundations, empirical findings, mediators, and intervention possibilities. Material and Methods: Peer-reviewed sources spanning minority stress theory, structural stigma, affective polarization, sport psychiatry, and elite sport mental health frameworks were appraised qualitatively for thematic relevance and applicability to sporting contexts. Results: Minority stressors may be associated with depression, anxiety, disordered eating, sleep disturbance, and altered physiological stress responses among athletes. Social polarization appears to interact with stigma processes, potentially amplifying their effects through cultural climates, online abuse, and contested policy debates. Protective factors such as social support, adaptive coping, mindfulness, self-compassion, and inclusive environments may moderate some of these effects. Conclusions: Mental health in sport may benefit from an ecologically informed approach attending to individual, interpersonal, organizational, and societal levels. Continued attention to minority stress and polarization seems warranted in research, clinical practice, and sport governance.

8 July 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
APArkadiusz Psiuk
Arkadiusz Psiuk
JSJoanna Szymocha
Joanna Szymocha
ISIgor SmęDowski
Igor SmęDowski
JTJarosław Tsukerman
Jarosław Tsukerman
AWAleksandra Wojas
Aleksandra Wojas
Background. The end of an elite sporting career is increasingly recognised not as a discrete event but as a prolonged transition during which many athletes lose a dominant athletic identity and confront fundamental questions about who they are outside sport. These identity disturbances and existential crises coincide with elevated psychological distress and with two frequently co-occurring addictions: alcohol use disorder and pathological gambling. Aim. This narrative review synthesises evidence on how identity disturbance and existential crisis surrounding athletic retirement may function as a predisposing substrate for the development of alcoholism and pathological gambling, and it compares the mechanisms, prevalence estimates, and moderators reported across the literature. Material and methods. A narrative review synthesised peer-reviewed conceptual analyses, systematic reviews, meta-analyses, and cohort and cross-sectional studies on athletic identity, career transition, mental health, alcohol use, and gambling in athletes, retrieved from PubMed, Scopus, Web of Science, and PsycINFO and interpreted qualitatively. Results. An exclusive athletic identity consistently predicted more difficult transitions, greater distress, and slower adjustment. Former athletes showed roughly twice the population prevalence of anxiety and depression, with substance misuse concentrated in subgroups burdened by pain, injury, and weak social support. Problem gambling was repeatedly elevated in male athletes, while alcohol and opioid pathways were tied to in-career culture, sensation seeking, and post-career self-medication. Conclusions. Identity disturbance and existential crisis appear to be plausible, partly modifiable contributors to addictive behaviour after sport, although direct longitudinal evidence remains scarce. Planned, gradual transitions, identity diversification, social-identity continuity, and proactive screening emerge as priority protective strategies.

14 July 2026 in Quality in Sport
Verified
Journal Article
Open access
APArkadiusz Adam Psiuk
Arkadiusz Adam Psiuk
JSJoanna Szymocha
Joanna Szymocha
JTJarosław Tsukerman
Jarosław Tsukerman
AWAleksandra Wojas
Aleksandra Wojas
RPRafał Pardela
Rafał Pardela
ISIgor SmęDowski
Igor SmęDowski
Background: Phthalates are diesters of phthalic acid used widely as plasticisers in plastics, food-contact materials, medical devices and personal-care products. As non-persistent endocrine-disrupting chemicals (EDCs), they may interfere with fetal androgen biosynthesis during the masculinisation programming window (MPW; 8–14 weeks' gestation) and have been associated with disorders collectively termed "phthalate syndrome". Aim: To synthesise current evidence on the proposed pathomechanistic axis linking maternal phthalate exposure with disrupted fetal steroidogenesis, the phenotype of testicular dysgenesis syndrome (TDS) and longer-term neurobehavioural and andrological consequences. Material and methods: PubMed/MEDLINE, Scopus, Web of Science and Embase were searched for original studies, reviews, meta-analyses and biomonitoring reports published 2000–2025, using "phthalates", "endocrine-disrupting chemicals", "Leydig cell", "INSL3", "anogenital distance", "testicular dysgenesis", "masculinisation programming window", "neurodevelopment", "autism" and "ADHD". Results: Reviewed evidence indicates that maternal monoester metabolites cross the placenta and may suppress steroidogenic transcripts (StAR, TSPO, CYP11A1, CYP17A1, 3β-HSD) and INSL3 in fetal Leydig cells. Several cohorts associate higher prenatal biomarkers with shortened anogenital distance and, less consistently, with cryptorchidism and hypospadias. Higher in utero exposure has further been linked with diminished male-typed play, autistic traits, ADHD symptomatology and compensated Leydig cell failure in adulthood. Conclusions: Prenatal phthalate exposure plausibly perturbs androgenic programming along a continuum extending from the gonad to the developing brain. Preventive public-health and preconceptional risk-reduction measures appear warranted.

12 July 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
APArkadiusz Psiuk
Arkadiusz Psiuk
JSJoanna Szymocha
Joanna Szymocha
ISIgor SmęDowski
Igor SmęDowski
JTJarosław Tsukerman
Jarosław Tsukerman
AWAleksandra Wojas
Aleksandra Wojas
Background: Although integral to overall well-being, sexual health remains a frequently overlooked component of sports medicine. Unlike the general population, the etiology of sexual dysfunction in elite athletes appears to be multifactorial and sport-specific, often involving relative energy deficiency in sport (RED-S), neuroendocrine stress, pelvic microtrauma, doping, and psychogenic burdens. Aim & Methods: This narrative review synthesizes current evidence and international guidelines to evaluate the etiopathogenesis of sexual dysfunction across different sports and to outline multidisciplinary management strategies. Results: Evidence indicates that the pathogenesis is markedly heterogeneous. In endurance and aesthetic disciplines, energy deficits and overtraining may suppress the hypothalamic-pituitary-gonadal axis, potentially leading to functional hypothalamic amenorrhea and related dyspareunia in women, and exercise-induced hypogonadotropic hypogonadism in men. Cycling and equestrian sports seem associated with neuromechanical injuries, particularly pudendal neuropathy, which may predispose athletes to erectile dysfunction and anorgasmia. Contact sports may increase the risk of secondary pituitary insufficiency following repetitive mild traumatic brain injury. In strength disciplines, body image disturbances and the sequelae of anabolic-androgenic steroid use appear as leading contributors. Across all sports, psychiatric morbidities and performance anxiety act as significant compounding factors, often exacerbated by systemic underreporting. Conclusions: Sexual dysfunction in athletes is a multidimensional, underdiagnosed condition that suggests a need for an individualized, biopsychosocial approach. Effective management likely necessitates interdisciplinary collaboration to address underlying pathologies through energy optimization, targeted psychotherapy, and cautiously applied, anti-doping-compliant pharmacotherapy.

17 July 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
APArkadiusz Adam Psiuk
Arkadiusz Adam Psiuk
JSJoanna Szymocha
Joanna Szymocha
JTJarosław Tsukerman
Jarosław Tsukerman
AWAleksandra Wojas
Aleksandra Wojas
Background: Caffeine is the most widely consumed psychoactive substance worldwide, yet its intake is rarely quantified in routine psychiatric or cardiological assessment. While IgE-mediated allergy appears exceptional, intolerance and hypersensitivity seem common and may reflect polygenic and metabolic variability that is often clinically underrecognised. Aim: To synthesise current evidence on caffeine pharmacokinetics, on the genetic determinants of inter-individual variability — particularly CYP1A2 and ADORA2A — and on clinically relevant interactions with psychotropic medications. Material and methods: A narrative review was performed using PubMed, Scopus and Google Scholar. Articles published in English addressing pharmacokinetics, pharmacogenomics, psychiatric symptomatology and drug–drug interactions of caffeine were considered. Original studies and reviews were included; case reports were retained when clinically illustrative. Results: Caffeine acts mainly through non-selective antagonism of A1 and A2A adenosine receptors, with downstream modulation of dopaminergic, noradrenergic and HPA-axis signalling. Variants of CYP1A2 (e.g. rs762551) define slow and rapid metabolisers, shaping plasma half-life and accumulation risk. ADORA2A polymorphisms (e.g. rs5751876) may modulate anxiogenic susceptibility independently of hepatic clearance. Co-administration with clozapine or olanzapine may raise plasma drug concentrations and toxicity risk; fluvoxamine, a potent CYP1A2 inhibitor, may extend the caffeine half-life severalfold, producing presentations easily mistaken for akathisia or serotonin syndrome. Conclusions: Caffeine intake — including hidden dietary and over-the-counter sources — should be systematically assessed before initiating psychotropic therapy. Pharmacogenomic profiling may support personalisation in treatment-resistant or atypically responsive patients.

12 July 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
APArkadiusz Psiuk
Arkadiusz Psiuk
JSJoanna Szymocha
Joanna Szymocha
ISIgor SmęDowski
Igor SmęDowski
JTJarosław Tsukerman
Jarosław Tsukerman
AWAleksandra Wojas
Aleksandra Wojas
Background: Major depressive disorder (MDD) poses a significant global burden. Since a large proportion of patients do not achieve full remission with standard pharmacotherapy alone, there is a pressing need for pleiotropic adjunctive interventions. Aim: To synthesize current evidence on the pleiotropic neurobiological, immunological, and gut-brain axis mechanisms that drive the antidepressant effects of physical activity. Material and methods: A narrative review of the medical literature was conducted using PubMed/MEDLINE, Web of Science, Scopus, and Google Scholar databases, covering the years 2003–2026. Ultimately, 33 research papers were included, with a particular focus on network meta-analyses and evidence-based medicine (EBM) clinical guidelines. Results: Structured physical exercise modulates the reactivity of the hypothalamic-pituitary-adrenal (HPA) axis to psychosocial stress and strongly stimulates neurogenesis in the atrophic hippocampus through the release of brain-derived neurotrophic factor (BDNF). Furthermore, recent studies highlight the critical role of contracting skeletal muscles as a detoxifying organ that converts neurotoxic kynurenine into kynurenic acid. Similarly, aerobic training strengthens the epithelial barrier and optimizes the gut microbiome, thereby suppressing systemic neuroinflammation. Conclusions: Physical activity appears to be a highly effective, multidirectional therapeutic intervention. Beyond alleviating core depressive symptoms with an efficacy comparable to standard psychopharmacotherapy, it is the only method that radically reduces premature cardiovascular mortality in this patient population.